Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | angiotensin-converting enzyme family protein | 0.0728 | 1 | 1 |
Onchocerca volvulus | Matrilysin homolog | 0.0211 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | extracellular metallopeptidase | 0.0355 | 0.2783 | 0.5 |
Loa Loa (eye worm) | matrixin family protein | 0.023 | 0.0369 | 0.0369 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0211 | 0 | 0.5 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0346 | 0.2614 | 0.5 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0346 | 0.2614 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Relative potency (binding) | = 3 | In vitro HMG-CoA reductase inhibitory activity required to inhibit cellular steroidgenesis in Hep G2 cells (human hepatoma cell line) with pravastatin as reference compound | ChEMBL. | 11392538 |
Relative potency (binding) | = 25 | In vitro rat HMG-CoA reductase inhibitory activity required to inhibit sterol synthesis in cell free system with pravastatin as reference compound | ChEMBL. | 11392538 |
Relative potency (binding) | = 3 | In vitro HMG-CoA reductase inhibitory activity required to inhibit cellular steroidgenesis in Hep G2 cells (human hepatoma cell line) with pravastatin as reference compound | ChEMBL. | 11392538 |
Relative potency (binding) | = 25 | In vitro rat HMG-CoA reductase inhibitory activity required to inhibit sterol synthesis in cell free system with pravastatin as reference compound | ChEMBL. | 11392538 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.